Simple vertebrate models for chemical genetics and drug discovery screens: Lessons from zebrafish and Xenopus

Developmental Dynamics

Volumn 238, Issue 6, 2009, Pages 1287-1308

  Wheeler, Grant N ^a   Brändli, André W ^b  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b ETH ZURICH   (Switzerland)

Author keywords

Chemical genetics; Chemical library; Chemical screening; Drug development; Drug discovery; Embryo; Embryogenesis; Organogenesis; Tadpole; Xenopus; Zebrafish

Indexed keywords

ANGIOGENESIS; CHEMICAL GENETICS; EMBRYO DEVELOPMENT; LYMPHANGIOGENESIS; NONHUMAN; ORGANOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; XENOPUS; ZEBRA FISH;

ANIMALS; BIOLOGICAL ASSAY; DRUG DISCOVERY; DRUG EVALUATION, PRECLINICAL; EVOLUTION; HUMANS; LYMPHANGIOGENESIS; MELANOCYTES; NEOVASCULARIZATION, PHYSIOLOGIC; PHENOTYPE; PHYLOGENY; REPRODUCIBILITY OF RESULTS; XENOPUS LAEVIS; ZEBRAFISH;

AMPHIBIA; ANIMALIA; ANURA; DANIO RERIO; MAMMALIA; VERTEBRATA;

EID: 66349117984     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.21967     Document Type: Review

References (139)

1. Adams DS, Levin M. 2006. Inverse drug screens: a rapid and inexpensive method for implicating molecular targets. Genesis 44:530-540. (Pubitemid 44846648)
2. Adams DS, Robinson KR, Fukumoto T, Yuan S, Albertson RC, Yelick P, Kuo L, McSweeney M, Levin M. 2006. Early, H+-V-ATPase-dependent proton flux is necessary for consistent left-right patterning of non-mammalian vertebrates. Development 133:1657-1671. (Pubitemid 43810973)
3. Adams DS, Masi A, Levin M. 2007. H+ pump-dependent changes in membrane voltage are an early mechanism necessary and sufficient to induce Xenopus tail regeneration. Development 134:1323-1335. (Pubitemid 46706039)
4. Ahn YH, Chang YT. 2007. Tagged small molecule library approach for facilitated chemical genetics. Acc Chem Res 40:1025-1033.
5. Alitalo K, Tammela T, Petrova TV. 2005. Lymphangiogenesis in development and human disease. Nature 438:946-953. (Pubitemid 43093960)
6. Barker N, Clevers H. 2006. Mining the Wnt pathway for cancer therapeutics. Nat Rev Drug Discov 5:997-1014. (Pubitemid 44835127)
7. Berger J, Currie P. 2007. The role of zebrafish in chemical genetics. Curr Med Chem 14:2413-2420. (Pubitemid 47618049)
8. Brändli AW. 2004. Prospects for the Xenopus embryo model in therapeutics technologies. Chimia 58:694-702. (Pubitemid 39523823)
9. Burdine L, Kodadek T. 2004. Target identification in chemical genetics: the (often) missing link. Chem Biol 11:593-597. (Pubitemid 38708828)
10. Burns CG, Milan DJ, Grande EJ, Rottbauer W, MacRae CA, Fishman MC. 2005. High-throughput assay for small molecules that modulate zebrafish embryonic heart rate. Nat Chem Biol 1:263-264.
11. Carmeliet P. 2003. Angiogenesis in health and disease. Nat Med 9:653-660. (Pubitemid 36749213)
12. Chan J, Serluca FC. 2004. Chemical approaches to angiogenesis. Methods Cell Biol 76:475-487. (Pubitemid 39752576)
13. Chan J, Bayliss PE, Wood JM, Roberts TM. 2002. Dissection of angiogenic signaling in zebrafish using a chemical genetic approach. Cancer Cell 1:257-267. (Pubitemid 41039150)
14. Chang S, Bray SM, Li Z, Zarnescu DC, He C, Jin P, Warren ST. 2008. Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila. Nat Chem Biol 4:256-263.
15. Chen Y, Pan FC, Brandes N, Afelik S, Solter M, Pieler T. 2004. Retinoic acid signaling is essential for pancreas development and promotes endocrine at the expense of exocrine cell differentiation in Xenopus. Dev Biol 271:144-160. (Pubitemid 38757782)
16. Christensen EI, Raciti D, Reggiani L, Verroust PJ, Brändli AW. 2008. Gene expression analysis defines the proximal tubule as the compartment for endocytic receptor-mediated uptake in the Xenopus pronephric kidney. Pflugers Arch 456:1163-1176.
17. Chung HA, Hyodo-Miura J, Kitayama A, Terasaka C, Nagamune T, Ueno N. 2004. Screening of FGF target genes in Xenopus by microarray: temporal dissection of the signalling pathway using a chemical inhibitor. Genes Cells 9:749-761. (Pubitemid 39206614)
18. Cleaver O, Krieg PA. 1998. VEGF mediates angioblast migration during development of the dorsal aorta in Xenopus. Development 125:3905-3914. (Pubitemid 28488365)
19. Courchesne CL, Bantle JA. 1985. Analysis of the activity of DNA, RNA, and protein synthesis inhibitors on Xenopus embryo development. Teratog Carcinog Mutagen 5:177-193. (Pubitemid 15071992)
20. Cox CM, D'Agostino SL, Miller MK, Heimark RL, Krieg PA. 2006. Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo. Dev Biol 296:177-189. (Pubitemid 44061763)
21. Cueni LN, Detmar M. 2006. New insights into the molecular control of the lymphatic vascular system and its role in disease. J Invest Dermatol 126:2167-2177. (Pubitemid 44413162)
22. Cuny GD, Yu PB, Laha JK, Xing X, Liu JF, Lai CS, Deng DY, Sachidanandan C, Bloch KD, Peterson RT. 2008. Structure-activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors. Bioorg Med Chem Lett 18:4388-4392.
23. Danielson PB. 2002. The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans. Curr Drug Metab 3:561-597. (Pubitemid 35331660)
24. Danilova N, Bussmann J, Jekosch K, Steiner LA. 2005. The immunoglobulin heavy-chain locus in zebrafish: identification and expression of a previously unknown isotype, immunoglobulin Z. Nat Immunol 6:295-302.
25. Davidson EH, Rast JP, Oliveri P, Ransick A, Calestani C, Yuh CH, Minokawa T, Amore G, Hinman V, Arenas-Mena C, Otim O, Brown CT, Livi CB, Lee PY, Revilla R, Rust AG, Pan Z, Schilstra MJ, Clarke PJ, Arnone MI, Rowen L, Cameron RA, McClay DR, Hood L, Bolouri H. 2002. A genomic regulatory network for development. Science 295:1669-1678. (Pubitemid 34202895)
26. Delaune E, Lemaire P, Kodjabachian L. 2005. Neural induction in Xenopus requires early FGF signalling in addition to BMP inhibition. Development 132:299-310. (Pubitemid 40268280)
27. Diamandis P, Wildenhain J, Clarke ID, Sacher AG, Graham J, Bellows DS, Ling EK, Ward RJ, Jamieson LG, Tyers M, Dirks PB. 2007. Chemical genetics reveals a complex functional ground state of neural stem cells. Nat Chem Biol 3:268-273. (Pubitemid 46625832)
28. Doyon Y, McCammon JM, Miller JC, Faraji F, Ngo C, Katibah GE, Amora R, Hocking TD, Zhang L, Rebar EJ, Gregory PD, Urnov FD, Amacher SL. 2008. Heritable targeted gene disruption in zebrafish using designed zinc-finger nucleases. Nat Biotechnol 26:702-708.
29. Du Pasquier L. 2001. The immune system of invertebrates and vertebrates. Comp Biochem Physiol B Biochem Mol Biol 129:1-15. (Pubitemid 32397705)
30. Du Pasquier L, Schwager J, Flajnik MF. 1989. The immune system of Xenopus. Annu Rev Immunol 7:251-275. (Pubitemid 19138014)
31. Dupre A, Boyer-Chatenet L, Sattler RM, Modi AP, Lee JH, Nicolette ML, Kopelovich L, Jasin M, Baer R, Paull TT, Gautier J. 2008. A forward chemical genetic screen reveals an inhibitor of the Mre11-Rad50-Nbs1 complex. Nat Chem Biol 4:119-125.
32. Emerson RO, Thomas JH. 2009. Adaptive evolution in zinc finger transcription factors. PLoS Genet 5:e1000325.
33. Fort DJ, Dawson DA, Bantle JA. 1988. Development of a metabolic activation system for the frog embryo teratogenesis assay: Xenopus (FETAX). Teratog Carcinog Mutagen 8:251-263. (Pubitemid 18274687)
34. Fort DJ, Stover EL, Bantle JA, Finch RA. 2000. Evaluation of the developmental toxicity of thalidomide using frog embryo teratogenesis assay-xenopus (FETAX): biotransformation and detoxification. Teratog Carcinog Mutagen 20:35-47. (Pubitemid 30036159)
35. Fukumoto T, Blakely R, Levin M. 2005a. Serotonin transporter function is an early step in left-right patterning in chick and frog embryos. Dev Neurosci 27:349-363. (Pubitemid 41567384)
36. Fukumoto T, Kema IP, Levin M. 2005b. Serotonin signaling is a very early step in patterning of the left-right axis in chick and frog embryos. Curr Biol 15:794-803. (Pubitemid 40689397)
37. Ghose AK, Viswanadhan VN, Wendoloski JJ. 1999. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. J Comb Chem 1:55-68.
38. Gibbs RA, Weinstock GM, Metzker ML, Muzny DM, Sodergren EJ, Scherer S, Scott G, Steffen D, Worley KC, Burch PE, Okwuonu G, Hines S, Lewis L, De-Ramo C, Delgado O, Dugan-Rocha S, Miner G, Morgan M, Hawes A, Gill R, Celera, Holt RA, Adams MD, Amanatides PG, Baden-Tillson H, Barnstead M, Chin S, Evans CA, Ferriera S, Fosler C, Glodek A, Gu Z, Jennings D, Kraft CL, Nguyen T, Pfannkoch CM, Sitter C, Sutton GG, Venter JC, Woodage T, Smith D, Lee HM, Gustafson E, Cahill P, Kana A, Doucette-Stamm L, Weinstock K, Fechtel K, Weiss RB, Dunn DM, Green ED, Blakesley RW, Bouffard GG, De Jong PJ, Osoegawa K, Zhu B, Marra M, Schein J, Bosdet I, Fjell C, Jones S, Krzywinski M, Mathewson C, Siddiqui A, Wye N, McPherson J, Zhao S, Fraser CM, Shetty J, Shatsman S, Geer K, Chen Y, Abramzon S, Nierman WC, Havlak PH, Chen R, Durbin KJ, Egan A, Ren Y, Song XZ, Li B, Liu Y, Qin X, Cawley S, Cooney AJ, D'Souza LM, Martin K, Wu JQ, Gonzalez-Garay ML, Jackson AR, Kalafus KJ, McLeod MP, Milosavljevic A, Virk D, Volkov A, Wheeler DA, Zhang Z, Bailey JA, Eichler EE, Tuzun E, Birney E, Mongin E, Ureta-Vidal A, Woodwark C, Zdobnov E, Bork P, Suyama M, Torrents D, Alexandersson M, Trask BJ, Young JM, Huang H, Wang H, Xing H, Daniels S, Gietzen D, Schmidt J, Stevens K, Vitt U, Wingrove J, Camara F, Mar Alba M, Abril JF, Guigo R, Smit A, Dubchak I, Rubin EM, Couronne O, Poliakov A, Hubner N, Ganten D, Goesele C, Hummel O, Kreitler T, Lee YA, Monti J, Schulz H, Zimdahl H, Himmelbauer H, Lehrach H, Jacob HJ, Bromberg S, Gullings-Handley J, Jensen-Seaman MI, Kwitek AE, Lazar J, Pasko D, Tonellato PJ, Twigger S, Ponting CP, Duarte JM, Rice S, Goodstadt L, Beatson SA, Emes RD, Winter EE, Webber C, Brandt P, Nyakatura G, Adetobi M, Chiaromonte F, Elnitski L, Eswara P, Hardison RC, Hou M, Kolbe D, Makova K, Miller W, Nekrutenko A, Riemer C, Schwartz S, Taylor J, Yang S, Zhang Y, Lindpaintner K, Andrews TD, Caccamo M, Clamp M, Clarke L, Curwen V, Durbin R, Eyras E, Searle SM, Cooper GM, Batzoglou S, Brudno M, Sidow A, Stone EA, Payseur BA, Bourque G, Lopez-Otin C, Puente XS, Chakrabarti K, Chatterji S, Dewey C, Pachter L, Bray N, Yap VB, Caspi A, Tesler G, Pevzner PA, Haussler D, Roskin KM, Baertsch R, Clawson H, Furey TS, Hinrichs AS, Karolchik D, Kent WJ, Rosenbloom KR, Trumbower H, Weirauch M, Cooper DN, Stenson PD, Ma B, Brent M, Arumugam M, Shteynberg D, Copley RR, Taylor MS, Riethman H, Mudunuri U, Peterson J, Guyer M, Felsenfeld A, Old S, Mockrin S, Collins F. 2004. Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature 428:493-521.
39. Goda T, Abu-Daya A, Carruthers S, Clark MD, Stemple DL, Zimmerman LB. 2006. Genetic screens for mutations affecting development of Xenopus tropicalis. PLoS Genet 2:e91. (Pubitemid 43998835)
40. Haggarty SJ, Mayer TU, Miyamoto DT, Fathi R, King RW, Mitchison TJ, Schreiber SL. 2000. Dissecting cellular processes using small molecules: identification of colchicine-like, taxol-like and other small molecules that perturb mitosis. Chem Biol 7:275-286. (Pubitemid 30199616)
41. Hathaway NA, King RW. 2005. Dissecting cell biology with chemical scalpels. Curr Opin Cell Biol 17:12-19. (Pubitemid 40138083)
42. Heasman J, Kofron M, Wylie C. 2000. Beta-catenin signaling activity dissected in the early Xenopus embryo: a novel anti-sense approach. Dev Biol 222:124-134. (Pubitemid 30387734)
43. Hedges SB. 2002. The origin and evolution of model organisms. Nat Rev Genet 3:838-849. (Pubitemid 35303516)
44. Hedges SB, Kumar S. 2002. Genomics. Vertebrate genomes compared. Science 297:1283-1285.
45. Helbling PM, Saulnier DM, Brändli AW. 2000. The receptor tyrosine kinase EphB4 and ephrin-B ligands restrict angiogenic growth of embryonic veins in Xenopus laevis. Development 127:269-278. (Pubitemid 30087964)
46. Hellsten U, Khokha MK, Grammer TC, Harland RM, Richardson P, Rokhsar DS. 2007. Accelerated gene evolution and subfunctionalization in the pseudotetraploid frog Xenopus laevis. BMC Biol 5:31. (Pubitemid 47308274)
47. Hong CC, Peterson QP, Hong JY, Peterson RT. 2006. Artery/vein specification is governed by opposing phosphatidylinositol-3 kinase and MAP kinase/ERK signaling. Curr Biol 16:1366-1372. (Pubitemid 43975369)
48. Jung DW, Williams D, Khersonsky SM, Kang TW, Heidary N, Chang YT, Orlow SJ. 2005. Identification of the F1F0 mitochondrial ATPase as a target for modulating skin pigmentation by screening a tagged triazine library in zebrafish. Mol Biosyst 1:85-92. (Pubitemid 43349734)
49. Kälin RE, Kretz MP, Meyer AM, Kispert A, Heppner FL, Brändli AW. 2007. Paracrine and autocrine mechanisms of apelin signaling govern embryonic and tumor angiogenesis. Dev Biol 305:599-614. (Pubitemid 46686624)
50. Kälin RE, Bänziger-Tobler NE, Detmar M, Brändli AW. 2009. An in vivo chemical screen in Xenopus tadpoles reveals novel pathways involved in angiogenesis and lymphangiogenesis. Blood (in press).
51. Kelsh RN, Schmid B, Eisen JS. 2000. Genetic analysis of melanophore development in zebrafish embryos. Dev Biol 225:277-293.
52. Kenwrick S, Amaya E, Papalopulu N. 2004. Pilot morpholino screen in Xenopus tropicalis identifies a novel gene involved in head development. Dev Dyn 229:289-299. (Pubitemid 38140467)
53. Khersonsky SM, Jung DW, Kang TW, Walsh DP, Moon HS, Jo H, Jacobson EM, Shetty V, Neubert TA, Chang YT. 2003. Facilitated forward chemical genetics using a tagged triazine library and zebrafish embryo screening. J Am Chem Soc 125:11804-11805. (Pubitemid 37175399)
54. Klein J, Nikolaidis N. 2005. The descent of the antibody-based immune system by gradual evolution. Proc Natl Acad Sci USA 102:169-174. (Pubitemid 40094447)
55. Koebernick K, Hollemann T, Pieler T. 2003. A restrictive role for Hedgehog signalling during otic specification in Xenopus. Dev Biol 260:325-338. (Pubitemid 36960082)
56. Landais I, Sobeck A, Stone S, LaChapelle A, Hoatlin ME. 2009. A novel cell-free screen identifies a potent inhibitor of the Fanconi anemia pathway. Int J Cancer 124:783-792.
57. Lepourcelet M, Chen YN, France DS, Wang H, Crews P, Petersen F, Bruseo C, Wood AW, Shivdasani RA. 2004. Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex. Cancer Cell 5:91-102. (Pubitemid 38121599)
58. Levin M, Thorlin T, Robinson KR, Nogi T, Mercola M. 2002. Asymmetries in H+/ K+-ATPase and cell membrane potentials comprise a very early step in left-right patterning. Cell 111:77-89.
59. Lieschke GJ, Currie PD. 2007. Animal models of human disease: zebrafish swim into view. Nat Rev Genet 8:353-367. (Pubitemid 46625809)
60. Lipinski CA. 2000. Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods 44:235-249. (Pubitemid 32239479)
61. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. 2001. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46:3-26.
62. Liu J, Wu X, Mitchell B, Kintner C, Ding S, Schultz PG. 2005. A small-molecule agonist of the Wnt signaling pathway. Angew Chem Int Ed Engl 44:1987-1990. (Pubitemid 40483016)
63. Liu XJ. 2006. Xenopus protocols: cell biology and signal transduction. Springer. 512 p.
64. Longo M, Zanoncelli S, Della Torre P, Rosa F, Giusti A, Colombo P, Brughera M, Mazue G, Olliaro P. 2008. Investigations of the effects of the antimalarial drug dihydroartemisinin (DHA) using the Frog Embryo Teratogenesis Assay-Xenopus (FETAX). Reprod Toxicol 25:433-441.
65. Margolis J, Plowman GD. 2004. Overcoming the gridlock in discovery research. Nat Biotechnol 22:522-524. (Pubitemid 38585901)
66. Maroon H, Walshe J, Mahmood R, Kiefer P, Dickson C, Mason I. 2002. Fgf3 and Fgf8 are required together for formation of the otic placode and vesicle. Development 129:2099-2108.
67. Mathew LK, Sengupta S, Kawakami A, Andreasen EA, Lohr CV, Loynes CA, Renshaw SA, Peterson RT, Tanguay RL. 2007. Unraveling tissue regeneration pathways using chemical genetics. J Biol Chem 282:35202-35210. (Pubitemid 350232466)
68. Meijer L, Skaltsounis AL, Magiatis P, Polychronopoulos P, Knockaert M, Leost M, Ryan XP, Vonica CA, Brivanlou A, Dajani R, Crovace C, Tarricone C, Musacchio A, Roe SM, Pearl L, Greengard P. 2003. GSK-3-selective inhibitors derived from Tyrian purple indirubins. Chem Biol 10:1255-1266. (Pubitemid 38050973)
69. Meng X, Noyes MB, Zhu LJ, Lawson ND, Wolfe SA. 2008. Targeted gene inactivation in zebrafish using engineered zinc-finger nucleases. Nat Biotechnol 26:695-701.
70. Metzstein MM, Stanfield GM, Horvitz HR. 1998. Genetics of programmed cell death in C. elegans: past, present and future. Trends Genet 14:410-416. (Pubitemid 28505585)
71. Milan DJ, Peterson TA, Ruskin JN, Peterson RT, MacRae CA. 2003. Drugs that induce repolarization abnormalities cause bradycardia in zebrafish. Circulation 107:1355-1358. (Pubitemid 36350731)
72. Min J, Kyung Kim Y, Cipriani PG, Kang M, Khersonsky SM, Walsh DP, Lee JY, Niessen S, Yates JR, 3rd, Gunsalus K, Piano F, Chang YT. 2007. Forward chemical genetic approach identifies new role for GAPDH in insulin signaling. Nat Chem Biol 3:55-59.
73. Mittelstadt SW, Hemenway CL, Craig MP, Hove JR. 2008. Evaluation of zebrafish embryos as a model for assessing inhibition of hERG. J Pharmacol Toxicol Methods 57:100-105.
74. Moens CB, Donn TM, Wolf-Saxon ER, Ma TP. 2008. Reverse genetics in zebrafish by TILLING. Brief Funct Genomic Proteomic 7:454-459.
75. Mohun TJ, Leong LM, Weninger WJ, Sparrow DB. 2000. The morphology of heart development in Xenopus laevis. Dev Biol 218:74-88. (Pubitemid 30085885)
76. Moon HS, Jacobson EM, Khersonsky SM, Luzung MR, Walsh DP, Xiong W, Lee JW, Parikh PB, Lam JC, Kang TW, Rosania GR, Schier AF, Chang YT. 2002. A novel microtubule destabilizing entity from orthogonal synthesis of triazine library and zebrafish embryo screening. J Am Chem Soc 124:11608-11609.
77. Murphey RD, Zon LI. 2006. Small molecule screening in the zebrafish. Methods 39:255-261. (Pubitemid 44209329)
78. Murphey RD, Stern HM, Straub CT, Zon LI. 2006. A chemical genetic screen for cell cycle inhibitors in zebrafish embryos. Chem Biol Drug Des 68:213-219. (Pubitemid 44760246)
79. Ni-Komatsu L, Orlow SJ. 2007. Identification of novel pigmentation modulators by chemical genetic screening. J Invest Dermatol 127:1585-1592. (Pubitemid 46933418)
80. North TE, Goessling W, Walkley CR, Lengerke C, Kopani KR, Lord AM, Weber GJ, Bowman TV, Jang IH, Grosser T, Fitzgerald GA, Daley GQ, Orkin SH, Zon LI. 2007. Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature 447:1007-1011. (Pubitemid 46975751)
81. Nusslein-Volhard C, Wieschaus E. 1980. Mutations affecting segment number and polarity in Drosophila. Nature 287:795-801. (Pubitemid 11214475)
82. Ny A, Koch M, Schneider M, Neven E, Tong RT, Maity S, Fischer C, Plaisance S, Lambrechts D, Heligon C, Terclavers S, Ciesiolka M, Kälin R, Man WY, Senn I, Wyns S, Lupu F, Brändli A, Vleminckx K, Collen D, Dewerchin M, Conway EM, Moons L, Jain RK, Carmeliet P. 2005. A genetic Xenopus laevis tadpole model to study lymphangiogenesis. Nat Med 11:998-1004. (Pubitemid 41294447)
83. Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L. 2006. VEGF receptor signalling: in control of vascular function. Nat Rev Mol Cell Biol 7:359-371.
84. Page-McCaw A, Ewald AJ, Werb Z. 2007. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 8:221-233. (Pubitemid 46310551)
85. Peterson JR, Lebensohn AM, Pelish HE, Kirschner MW. 2006. Biochemical suppression of small-molecule inhibitors: a strategy to identify inhibitor targets and signaling pathway components. Chem Biol 13:443-452.
86. Peterson RT, Fishman MC. 2004. Discovery and use of small molecules for probing biological processes in zebrafish. Methods Cell Biol 76:569-591. (Pubitemid 39752581)
87. Peterson RT, Link BA, Dowling JE, Schreiber SL. 2000. Small molecule developmental screens reveal the logic and timing of vertebrate development. Proc Natl Acad Sci USA 97:12965-12969.
88. Peterson RT, Mably JD, Chen JN, Fishman MC. 2001. Convergence of distinct pathways to heart patterning revealed by the small molecule concentramide and the mutation heart-and-soul. Curr Biol 11:1481-1491. (Pubitemid 32931009)
89. Peterson RT, Shaw SY, Peterson TA, Milan DJ, Zhong TP, Schreiber SL, MacRae CA, Fishman MC. 2004. Chemical suppression of a genetic mutation in a zebrafish model of aortic coarctation. Nat Biotechnol 22:595-599. (Pubitemid 38585912)
90. Postlethwait JH. 2007. The zebrafish genome in context: ohnologs gone missing. J Exp Zool B Mol Dev Evol 308:563-577. (Pubitemid 47528915)
91. Postlethwait JH, Yan YL, Gates MA, Horne S, Amores A, Brownlie A, Donovan A, Egan ES, Force A, Gong Z, Goutel C, Fritz A, Kelsh R, Knapik E, Liao E, Paw B, Ransom D, Singer A, Thomson M, Abduljabbar TS, Yelick P, Beier D, Joly JS, Larhammar D, Rosa F, Westerfield M, Zon LI, Johnson SL, Talbot WS. 1998. Vertebrate genome evolution and the zebrafish gene map. Nat Genet 18:345-349. (Pubitemid 28158162)
92. Raciti D, Reggiani L, Geffers L, Jiang Q, Bacchion F, Subrizi AE, Clements D, Tindal C, Davidson DR, Kaissling B, Brändli AW. 2008. Organization of the pronephric kidney revealed by large-scale gene expression mapping. Genome Biol 9:R84.
93. Raible F, Brand M. 2001. Tight transcriptional control of the ETS domain factors Erm and Pea3 by Fgf signaling during early zebrafish development. Mech Dev 107:105-117. (Pubitemid 32755809)
94. Rana AA, Collart C, Gilchrist MJ, Smith JC. 2006. Defining synphenotype groups in Xenopus tropicalis by use of antisense morpholino oligonucleotides. PLoS Genet 2:e193. (Pubitemid 44813574)
95. Reya T, Clevers H. 2005. Wnt signalling in stem cells and cancer. Nature 434:843-850. (Pubitemid 40558990)
96. Richards SM, Cole SE. 2006. A toxicity and hazard assessment of fourteen pharmaceuticals to Xenopus laevis larvae. Ecotoxicology 15:647-656. (Pubitemid 44764295)
97. Rickardson L, Fryknas M, Haglund C, Lovborg H, Nygren P, Gustafsson MG, Isaksson A, Larsson R. 2006. Screening of an annotated compound library for drug activity in a resistant myeloma cell line. Cancer Chemother Pharmacol 58:749-758. (Pubitemid 44351254)
98. Root DE, Flaherty SP, Kelley BP, Stockwell BR. 2003. Biological mechanism profiling using an annotated compound library. Chem Biol 10:881-892. (Pubitemid 37171905)
99. Rubinstein AL. 2003. Zebrafish: from disease modeling to drug discovery. Curr Opin Drug Discov Dev 6:218-223. (Pubitemid 36368376)
100. Sachidanandan C, Yeh JR, Peterson QP, Peterson RT. 2008. Identification of a novel retinoid by small molecule screening with zebrafish embryos. PLoS ONE 3:e1947.
101. Schreiber SL. 2000. Target-oriented and diversity-oriented organic synthesis in drug discovery. Science 287:1964-1969. (Pubitemid 30158663)
102. Segalat L. 2007. Invertebrate animal models of diseases as screening tools in drug discovery. ACS Chem Biol 2:231-236. (Pubitemid 47629209)
103. Serbedzija GN, Flynn E, Willett CE. 1999. Zebrafish angiogenesis: a new model for drug screening. Angiogenesis 3:353-359. (Pubitemid 129643978)
104. Shafizadeh E, Peterson RT, Lin S. 2004. Induction of reversible hemolytic anemia in living zebrafish using a novel small molecule. Comp Biochem Physiol C Toxicol Pharmacol 138:245-249. (Pubitemid 39469059)
105. Shan J, Shi DL, Wang J, Zheng J. 2005. Identification of a specific inhibitor of the dishevelled PDZ domain. Biochemistry 44:15495-15503. (Pubitemid 41706133)
106. Shin JT, Fishman MC. 2002. From Zebrafish to human: modular medical models. Annu Rev Genomics Hum Genet 3:311-340. (Pubitemid 35217440)
107. Shinya M, Koshida S, Sawada A, Kuroiwa A, Takeda H. 2001. Fgf signalling through MAPK cascade is required for development of the subpallial telencephalon in zebrafish embryos. Development 128:4153-4164. (Pubitemid 33077028)
108. Spring DR, Krishnan S, Blackwell HE, Schreiber SL. 2002. Diversity-oriented synthesis of biaryl-containing medium rings using a one bead/one stock solution platform. J Am Chem Soc 124:1354-1363. (Pubitemid 34169142)
109. Stainier DY. 2001. Zebrafish genetics and vertebrate heart formation. Nat Rev Genet 2:39-48. (Pubitemid 33674768)
110. Stemple DL. 2004. TILLING: a high-throughput harvest for functional genomics. Nat Rev Genet 5:145-150. (Pubitemid 38160281)
111. Stern HM, Murphey RD, Shepard JL, Amatruda JF, Straub CT, Pfaff KL, Weber G, Tallarico JA, King RW, Zon LI. 2005. Small molecules that delay S phase suppress a zebrafish bmyb mutant. Nat Chem Biol 1:366-370.
112. Sternson SM, Louca JB, Wong JC, Schreiber SL. 2001. Split-pool synthesis of 1,3-dioxanes leading to arrayed stock solutions of single compounds sufficient for multiple phenotypic and protein-binding assays. J Am Chem Soc 123:1740-1747. (Pubitemid 32179424)
113. Stockwell BR. 2000. Chemical genetics: ligand-based discovery of gene function. Nat Rev Genet 1:116-125.
114. Stockwell BR. 2004. Exploring biology with small organic molecules. Nature 432:846-854. (Pubitemid 40037140)
115. Sturm RA. 2009. Molecular genetics of human pigmentation diversity. Hum Mol Genet 18:R9-17.
116. Thomas I, Kihiczak GG, Fox MD, Janniger CK, Schwartz RA. 2004. Piebaldism: an update. Int J Dermatol 43:716-719. (Pubitemid 39405852)
117. Tomlinson M, Field RA, Wheeler GN. 2005. Xenopus as a model organism in developmental chemical genetic screens. Molecular BioSystems 1:223-228. (Pubitemid 41442432)
118. Tomlinson ML, Guan P, Morris RJ, Fidock MD, Rejzek M, Garcia-Morales C, Field RA, Wheeler GN. 2009a. A chemical genomic approach identifies matrix metalloproteinases as playing an essential and specific role in Xenopus melanophore migration. Chem Biol 16:93-104.
119. Tomlinson ML, Rejzek M, Fidock M, Field RA, Wheeler GN. 2009b. Chemical genomics identifies compounds affecting Xenopus laevis pigment cell development Molecular BioSystems 5:376-384.
120. Towbin JA, McQuinn TC. 1995. Gridlock: a model for coarctation of the aorta? Nat Med 1:1141-1142.
121. Tran TC, Sneed B, Haider J, Blavo D, White A, Aiyejorun T, Baranowski TC, Rubinstein AL, Doan TN, Dingledine R, Sandberg EM. 2007. Automated, quantitative screening assay for antiangiogenic compounds using transgenic zebrafish. Cancer Res 67:11386-11392. (Pubitemid 350248566)
122. Traver D, Herbomel P, Patton EE, Murphey RD, Yoder JA, Litman GW, Catic A, Amemiya CT, Zon LI, Trede NS. 2003. The zebrafish as a model organism to study development of the immune system. Adv Immunol 81:253-330. (Pubitemid 38009045)
123. Ureta-Vidal A, Ettwiller L, Birney E. 2003. Comparative genomics: genome-wide analysis in metazoan eukaryotes. Nat Rev Genet 4:251-262. (Pubitemid 36389530)
124. van Kempen LC, Coussens LM. 2002. MMP9 potentiates pulmonary metastasis formation. Cancer Cell 2:251-252. (Pubitemid 41043957)
125. Van Raay TJ, Vetter ML. 2004. Wnt/frizzled signaling during vertebrate retinal development. Dev Neurosci 26:352-358. (Pubitemid 40663243)
126. Verma R, Peters NR, D'Onofrio M, Tochtrop GP, Sakamoto KM, Varadan R, Zhang M, Coffino P, Fushman D, Deshaies RJ, King RW. 2004. Ubistatins inhibit proteasome-dependent degradation by binding the ubiquitin chain. Science 306:117-120. (Pubitemid 39451952)
127. Vismara C, Caloni F. 2007. Evaluation of aflatoxin B1 embryotoxicity using the frog embryo teratogenesis assay-Xenopus and bio-activation with microsome activation systems. Birth Defects Res B Dev Reprod Toxicol 80:183-187. (Pubitemid 47047367)
128. Warkman AS, Krieg PA. 2007. Xenopus as a model system for vertebrate heart development. Semin Cell Dev Biol 18:46-53. (Pubitemid 46330842)
129. White RM, Zon LI. 2008. Melanocytes in development, regeneration, and cancer. Cell Stem Cell 3:242-252.
130. White RM, Sessa A, Burke C, Bowman T, LeBlanc J, Ceol C, Bourque C, Dovey M, Goessling W, Burns CE, Zon LI. 2008. Transparent adult zebrafish as a tool for in vivo transplantation analysis. Cell Stem Cell 2:183-189.
131. Wienholds E, van Eeden F, Kosters M, Mudde J, Plasterk RH, Cuppen E. 2003. Efficient target-selected mutagenesis in zebrafish. Genome Res 13:2700-2707. (Pubitemid 37541159)
132. Wignall SM, Gray NS, Chang YT, Juarez L, Jacob R, Burlingame A, Schultz PG, Heald R. 2004. Identification of a novel protein regulating microtubule stability through a chemical approach. Chem Biol 11:135-146. (Pubitemid 38203998)
133. Wong JC, Sternson SM, Louca JB, Hong R, Schreiber SL. 2004. Modular synthesis and preliminary biological evaluation of stereochemically diverse 1,3-dioxanes. Chem Biol 11:1279-1291. (Pubitemid 39282802)
134. Yu PB, Deng DY, Lai CS, Hong CC, Cuny GD, Bouxsein ML, Hong DW, McManusPM, Katagiri T, Sachidanandan C, Kamiya N, Fukuda T, Mishina Y, Peterson RT, Bloch KD. 2008a. BMP type I receptor inhibition reduces heterotopic ossification. Nat Med 14:1363-1369.
135. Yu PB, Hong CC, Sachidanandan C, Babitt JL, Deng DY, Hoyng SA, Lin HY, Bloch KD, Peterson RT. 2008b. Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat Chem Biol 4:33-41. (Pubitemid 350273653)
136. Zhang Q, Major MB, Takanashi S, Camp ND, Nishiya N, Peters EC, Ginsberg MH, Jian X, Randazzo PA, Schultz PG, Moon RT, Ding S. 2007. Small-molecule synergist of the Wnt/beta-catenin signaling pathway. Proc Natl Acad Sci USA 104:7444-7448. (Pubitemid 47185925)
137. Zhong TP, Rosenberg M, Mohideen MA, Weinstein B, Fishman MC. 2000. gridlock, an HLH gene required for assembly of the aorta in zebrafish. Science 287:1820-1824. (Pubitemid 30143966)
138. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, Moller DE. 2001. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108:1167-1174.
139. Zon LI, Peterson RT. 2005. In vivo drug discovery in the zebrafish. Nat Rev Drug Discov 4:35-44.